[{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Moderator","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Gautam Mehta<\/i><\/u><\/presenter>. U.S. Food and Drug Administration, Silver Spring, MD","CSlideId":"","ControlKey":"32ea5e27-604f-46ac-960f-0c859a37cfb8","ControlNumber":"8276","DisclosureBlock":"&nbsp;<b>G. Mehta:<\/b> None.","End":"4\/11\/2022 12:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"14094","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"1","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Gautam Mehta, MD","PresenterKey":"c49b3610-8d30-4885-93d2-30a4b0fbc591","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Moderator","SearchResultFooter":"","SearchResultHeader":"Apr 11 2022 12:30PM","SessionId":"487","SessionOnDemand":"False","SessionTitle":"Accelerated, Conditional, Provisional, or Temporary? A Comparison of International Expedited Approval Programs","ShowChatLink":"false","Start":"4\/11\/2022 12:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Moderator","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Lauren Tesh Hotaki<\/i><\/u><\/presenter>. U.S. Food and Drug Administration, Silver Spring, MD","CSlideId":"","ControlKey":"4d746b9e-e8e7-4f9a-b081-efca23500727","ControlNumber":"9483","DisclosureBlock":"&nbsp;<b>L. Tesh Hotaki, <\/b> None.","End":"4\/11\/2022 12:35:00 PM","HasWebcast":null,"Highlights":[],"Id":"20932","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"2","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Lauren Tesh Hotaki, Pharm.D., BCPS, BCIDP","PresenterKey":"4ed2206a-1971-47f0-9dc3-559aeb05a2ca","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Introduction and overview of Project Orbis and international regulatory collaboration","SearchResultFooter":"","SearchResultHeader":"Apr 11 2022 12:30PM","SessionId":"487","SessionOnDemand":"False","SessionTitle":"Accelerated, Conditional, Provisional, or Temporary? A Comparison of International Expedited Approval Programs","ShowChatLink":"false","Start":"4\/11\/2022 12:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Introduction and overview of Project Orbis and international regulatory collaboration","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Gautam Mehta<\/i><\/u><\/presenter>. U.S. Food and Drug Administration, Silver Spring, MD","CSlideId":"","ControlKey":"12965cf4-8e84-4c8d-8f58-411f6bc9352e","ControlNumber":"9511","DisclosureBlock":"","End":"4\/11\/2022 12:45:00 PM","HasWebcast":null,"Highlights":[],"Id":"20960","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"3","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Gautam Mehta, MD","PresenterKey":"c49b3610-8d30-4885-93d2-30a4b0fbc591","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Overview of the Accelerated Approval program in the US","SearchResultFooter":"","SearchResultHeader":"Apr 11 2022 12:30PM","SessionId":"487","SessionOnDemand":"False","SessionTitle":"Accelerated, Conditional, Provisional, or Temporary? A Comparison of International Expedited Approval Programs","ShowChatLink":"false","Start":"4\/11\/2022 12:35:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Overview of the Accelerated Approval program in the US","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Francesco Pignatti<\/i><\/u><\/presenter>. The European Medicines Agency, London, United Kingdom","CSlideId":"","ControlKey":"a25583bc-9537-4254-acb9-4e9e47e993df","ControlNumber":"9478","DisclosureBlock":"","End":"4\/11\/2022 12:55:00 PM","HasWebcast":null,"Highlights":[],"Id":"20927","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"4","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Francesco Pignatti, 00","PresenterKey":"6a11f7b1-c958-454c-818a-a957f760e98d","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Overview of Conditional Marketing Authorization in the EU","SearchResultFooter":"","SearchResultHeader":"Apr 11 2022 12:30PM","SessionId":"487","SessionOnDemand":"False","SessionTitle":"Accelerated, Conditional, Provisional, or Temporary? A Comparison of International Expedited Approval Programs","ShowChatLink":"false","Start":"4\/11\/2022 12:45:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Overview of Conditional Marketing Authorization in the EU","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Ulrich-Peter Rohr<\/i><\/u><\/presenter>. Swissmedic Swiss Agency for Therapeutic Products, Bern, Switzerland","CSlideId":"","ControlKey":"3084865a-89f4-41bd-94ba-c5427d4fec70","ControlNumber":"9481","DisclosureBlock":"&nbsp;<b>U. Rohr, <\/b> None.","End":"4\/11\/2022 1:05:00 PM","HasWebcast":null,"Highlights":[],"Id":"20930","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"5","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Ulrich-Peter Rohr, MD, PhD","PresenterKey":"48f41a48-72ad-4a5c-8c53-ea1f842b276a","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Overview of Temporary Authorization in Switzerland","SearchResultFooter":"","SearchResultHeader":"Apr 11 2022 12:30PM","SessionId":"487","SessionOnDemand":"False","SessionTitle":"Accelerated, Conditional, Provisional, or Temporary? A Comparison of International Expedited Approval Programs","ShowChatLink":"false","Start":"4\/11\/2022 12:55:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Overview of Temporary Authorization in Switzerland","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Angelo De Claro<\/i><\/u><\/presenter>. U.S. Food and Drug Administration, Silver Spring, MD","CSlideId":"","ControlKey":"96656478-8b8d-4c1e-8a3a-de50ef598788","ControlNumber":"9473","DisclosureBlock":"&nbsp;<b>A. de Claro, <\/b> None.","End":"4\/11\/2022 1:15:00 PM","HasWebcast":null,"Highlights":[],"Id":"20922","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"6","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Angelo de Claro, MD","PresenterKey":"f0210862-50d5-43d3-81d6-9aaf0a89b2e6","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Panelist","SearchResultFooter":"","SearchResultHeader":"Apr 11 2022 12:30PM","SessionId":"487","SessionOnDemand":"False","SessionTitle":"Accelerated, Conditional, Provisional, or Temporary? A Comparison of International Expedited Approval Programs","ShowChatLink":"false","Start":"4\/11\/2022 1:05:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Panelist","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Michael Shum<\/i><\/u><\/presenter>. Australian Government Department of Health, Canberra, Australia","CSlideId":"","ControlKey":"aab5c54f-bb63-4a56-a97b-6f52b5597109","ControlNumber":"10085","DisclosureBlock":"","End":"4\/11\/2022 1:25:00 PM","HasWebcast":null,"Highlights":[],"Id":"21773","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"7","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Michael Shum","PresenterKey":"68221523-090b-4ea5-b849-07c8dea81bf4","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Speaker","SearchResultFooter":"","SearchResultHeader":"Apr 11 2022 12:30PM","SessionId":"487","SessionOnDemand":"False","SessionTitle":"Accelerated, Conditional, Provisional, or Temporary? A Comparison of International Expedited Approval Programs","ShowChatLink":"false","Start":"4\/11\/2022 1:15:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Speaker","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>LeAnne Nelson<\/i><\/u><\/presenter>. Australian Government Department of Health, Canberra, Australia","CSlideId":"","ControlKey":"48ae4502-a783-45a3-8bef-bb6c479b17ac","ControlNumber":"10070","DisclosureBlock":"","End":"4\/11\/2022 1:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"21738","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"8","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"LeAnne Nelson","PresenterKey":"6fe93121-f2af-4d23-8b94-f47b849d414e","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Panelist","SearchResultFooter":"","SearchResultHeader":"Apr 11 2022 12:30PM","SessionId":"487","SessionOnDemand":"False","SessionTitle":"Accelerated, Conditional, Provisional, or Temporary? A Comparison of International Expedited Approval Programs","ShowChatLink":"false","Start":"4\/11\/2022 1:25:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Panelist","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Kaye Robertson<\/i><\/u><\/presenter>. Australian Government Department of Health, Canberra, Australia","CSlideId":"","ControlKey":"77c251a3-d3af-4045-b090-2e719113c1b9","ControlNumber":"10069","DisclosureBlock":"","End":"4\/11\/2022 1:35:00 PM","HasWebcast":null,"Highlights":[],"Id":"21737","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"9","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Kaye Robertson","PresenterKey":"11eddf04-7857-41c7-8535-6a6053d138d2","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Panelist","SearchResultFooter":"","SearchResultHeader":"Apr 11 2022 12:30PM","SessionId":"487","SessionOnDemand":"False","SessionTitle":"Accelerated, Conditional, Provisional, or Temporary? A Comparison of International Expedited Approval Programs","ShowChatLink":"false","Start":"4\/11\/2022 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Panelist","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Discussion Discussion<\/i><\/u><\/presenter>. ","CSlideId":"","ControlKey":"de2c4a0e-6f2d-43ac-a8fd-696c5f541a9e","ControlNumber":"9560","DisclosureBlock":"","End":"4\/11\/2022 1:45:00 PM","HasWebcast":null,"Highlights":[],"Id":"21011","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"10","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Discussion","PresenterKey":"deb5c591-17a4-4ab5-8ca3-a990c8489b4b","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Roundtable Discussion: Evidence to support expedited approvals","SearchResultFooter":"","SearchResultHeader":"Apr 11 2022 12:30PM","SessionId":"487","SessionOnDemand":"False","SessionTitle":"Accelerated, Conditional, Provisional, or Temporary? A Comparison of International Expedited Approval Programs","ShowChatLink":"false","Start":"4\/11\/2022 1:35:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Roundtable Discussion: Evidence to support expedited approvals","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Discussion Discussion<\/i><\/u><\/presenter>. ","CSlideId":"","ControlKey":"aef066e2-29ae-4176-bf59-29f01ba8b25f","ControlNumber":"9561","DisclosureBlock":"","End":"4\/11\/2022 1:55:00 PM","HasWebcast":null,"Highlights":[],"Id":"21012","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"11","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Discussion","PresenterKey":"deb5c591-17a4-4ab5-8ca3-a990c8489b4b","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Roundtable Discussion: Time limitations for expedited approvals","SearchResultFooter":"","SearchResultHeader":"Apr 11 2022 12:30PM","SessionId":"487","SessionOnDemand":"False","SessionTitle":"Accelerated, Conditional, Provisional, or Temporary? A Comparison of International Expedited Approval Programs","ShowChatLink":"false","Start":"4\/11\/2022 1:45:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Roundtable Discussion: Time limitations for expedited approvals","Topics":null,"cSlideId":""}]